KAMM; Walter

Patent Applications and Registrations

Patent applications and USPTO patent grants for KAMM; Walter.The latest application filed is for "liquid pharmaceutical composition".

Company Profile

3.7.24

KAMM; Walter - Frankfurt am Main DE
Kamm; Walter - Idstein DE
Kamm; Walter - Hofheim DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Liquid Pharmaceutical Composition App 20220160837 - VENCZEL; Marta ; et al.	2022-05-26
Stabilized Pharmaceutical Formulations Of Insulin Analogues And/or Insulin Derivatives App 20220040267 - Bley; Oliver ; et al.	2022-02-10
Stabilized Pharmaceutical Formulations Of Insulin Aspart App 20220023392 - Bley; Oliver ; et al.	2022-01-27
Stabilized Pharmaceutical Formulations Of Insulin Analogues And/or Insulin Derivatives App 20210077589 - BLEY; Oliver ; et al.	2021-03-18
Stabilized Pharmaceutical Formulations Of Insulin Analogues And/or Insulin Derivatives App 20200297852 - Bley; Oliver ; et al.	2020-09-24
Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives Grant 10,610,595 - Bley , et al.	2020-04-07
Otamixaban formulations with improved stability Grant 9,993,464 - Kamm , et al. June 12, 2	2018-06-12
Stabilized Pharmaceutical Formulations Of Insulin Analogues And/or Insulin Derivatives App 20180125945 - Bley; Oliver ; et al.	2018-05-10
Stabilized Pharmaceutical Formulations Of Insulin Analogues And/or Insulin Derivatives App 20180125981 - Bley; Oliver ; et al.	2018-05-10
Stabilized Pharmaceutical Formulations Of Insulin Aspart App 20180125944 - Bley; Oliver ; et al.	2018-05-10
Stabilized Pharmaceutical Formulations Of Insulin Analogues And/or Insulin Derivatives App 20180125943 - BLEY; Oliver ; et al.	2018-05-10
Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives Grant 9,895,424 - Bley , et al. February 20, 2	2018-02-20
Stabilized pharmaceutical formulations of insulin aspart Grant 9,895,423 - Bley , et al. February 20, 2	2018-02-20
Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives Grant 9,839,675 - Bley , et al. December 12, 2	2017-12-12
Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives Grant 9,839,692 - Bley , et al. December 12, 2	2017-12-12
Otamixaban Formulations With Improved Stability App 20170224668 - KAMM; Walter ; et al.	2017-08-10
Stabilized Pharmaceutical Formulations of Insulin Analogues and/or Insulin Derivatives App 20150216981 - Bley; Oliver ; et al.	2015-08-06
Stabilized Pharmaceutical Formulations of Insulin Analogues and/or Insulin Derivatives App 20150216941 - Bley; Oliver ; et al.	2015-08-06
Stabilized Pharmaceutical Formulations Of Insulin Aspart App 20150190475 - Bley; Oliver ; et al.	2015-07-09
Stabilized Pharmaceutical Formulations Of Insulin Analogues And/or Insulin Derivatives App 20140221285 - BLEY; Oliver ; et al.	2014-08-07
Otamixaban Formulations With Improved Stability App 20140018398 - Kamm; Walter ; et al.	2014-01-16
Otamixaban Formulations With Improved Stability App 20120252852 - KAMM; Walter ; et al.	2012-10-04
Insulin Preparations Containing Methionine App 20120252724 - Schoettle; Isabell ; et al.	2012-10-04
Slow-acting Insulin Preparations App 20120232002 - Schoettle; Isabell ; et al.	2012-09-13
Medicinal lipolysis of accumulation of fat App 20100004216 - Boderke; Peter ; et al.	2010-01-07
Inhibitors Of The Task-1 And Task-3 Ion Channel App 20090149496 - BRENDEL; Joachim ; et al.	2009-06-11
Medicinal lipolysis of accumulations of fat App 20050143347 - Boderke, Peter ; et al.	2005-06-30
Self-assembling colloidal carriers for protein delivery Grant 6,616,944 - Kissel , et al. September 9, 2	2003-09-09
Self-assembling colloidal carriers for protein delivery App 20010047074 - Kissel, Thomas ; et al.	2001-11-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.